Strengths

COR’s negative cash conversion cycle indicates working-capital efficiency that supports liquidity and cash generation better than many peers in distribution-heavy industrials.

Return on invested capital of 12.7% suggests disciplined capital deployment, implying COR converts invested capital into returns more effectively than lower-return peers.

The company’s scale and broad healthcare distribution footprint create purchasing and logistics leverage that typically improves service reliability versus smaller regional competitors.

Recurring demand from healthcare providers and pharmacies gives COR a more defensive revenue base than peers tied to more cyclical end markets.

Weaknesses

Net debt to EBITDA of 1.7x leaves COR more levered than conservatively financed peers, reducing flexibility if margins or volumes weaken.

Debt to equity of 3.6x indicates a heavier balance-sheet burden than many peers, which can constrain capital allocation and raise refinancing sensitivity.

Current ratio below 1.0 suggests short-term liquidity is tighter than stronger peers, increasing dependence on efficient cash collection and supplier terms.

Quick ratio of 0.58x shows limited near-cash coverage versus peers, making COR more exposed to working-capital shocks despite its efficient cash cycle.

Opportunities

Healthcare utilization growth can expand COR’s distribution volumes, and its scale positions it to capture more share than smaller peers as demand rises.

Ongoing consolidation among providers and pharmacies can favor large distributors like COR, because integrated customers often prefer national scale and service breadth.

Further automation and route optimization could widen COR’s working-capital advantage versus peers, supporting incremental margin and cash-flow improvement.

If COR deepens specialty and value-added services, it could improve mix and strengthen its competitive position relative to commodity-focused distributors.

Threats

Intense pricing pressure from large peers can compress distribution margins, because COR’s scale advantages do not fully eliminate customer bargaining power.

Regulatory and reimbursement changes in healthcare can shift purchasing behavior, potentially favoring peers with more specialized or vertically integrated models.

Supplier concentration and product shortages can disrupt service levels, and larger peers may secure inventory more effectively during tight supply conditions.

Higher leverage leaves COR more vulnerable than low-debt peers if interest rates stay elevated, since financing costs can absorb operating gains.

Overall Score

COR appears structurally solid versus peers on working-capital efficiency and capital returns, but balance-sheet leverage and liquidity keep its overall positioning in the moderate range.